Key Points
  1. Totals represent funding specifically designated by donor governments for family planning as defined by the OECD DAC (see methodology), and include: standalone family planning projects; family planning-specific contributions to multilateral organizations (e.g., contributions to UNFPA Supplies); and, in some cases, projects that include family planning within broader reproductive health activities.

    ← Return to text

  2. In FY 2019, a comparable figure for funding disbursed was not available due to adjustments made in USAID’s accounting system. Instead, the FY 2019 total is based on Congressionally appropriated amounts, which include US$575.0 million in funding for family planning as well as US$17.5 million transferred to family planning from the Congressional appropriation to UNFPA (see Donor Contributions to UNFPA section for additional details). It is important to note that U.S. appropriations for a given year may be disbursed over a multi-year period. Appropriations have remained relatively flat for several years while disbursements have fluctuated largely due to the timing of payments.

    ← Return to text

  3. Includes core-contributions from members of the OECD DAC only; core contributions from non-DAC donors are not included in this total.

    ← Return to text

  4. UNFPA, “UNFPA in 2019: Annual Report”, 2019. See also UNFPA Donor Contributions portal.

    ← Return to text

  5. In FY17, FY18, and FY19, the U.S. administration invoked the Kemp-Kasten amendment to withhold funding – both core and non-core contributions – to UNFPA. In each of these years, Congress required that funding withheld from UNFPA “shall be made available for family planning, maternal, and reproductive health activities.” See KFF “UNFPA Funding & Kemp-Kasten: An Explainer” for additional details.

    ← Return to text

Report
  1. Includes funding from 29 DAC member countries and the European Union (EU).

    ← Return to text

  2. Totals represent funding specifically designated by donor governments for family planning as defined by the OECD DAC (see methodology), and include: standalone family planning projects; family planning-specific contributions to multilateral organizations (e.g., contributions to UNFPA Supplies); and, in some cases, projects that include family planning within broader reproductive health activities.

    ← Return to text

  3. Funding amounts specified by Congress are for a given fiscal year (the U.S. fiscal year is from October 1 to September 30), but may be spent over a multi-year period. Because funding may be spent over a multi-year period, disbursements may lag or vary from appropriations due to a variety of factors including a realignment of the program or the timing of reimbursement requests from an implementing partner, but will eventually be spent.

    ← Return to text

  4. In FY 2019, a comparable figure for funding disbursed was not available due to adjustments made in USAID’s accounting system. Instead, the FY 2019 total is based on Congressionally appropriated amounts, which include US$575.0 million in funding for family planning as well as US$17.5 million transferred to family planning from the Congressional appropriation to UNFPA (see Donor Contributions to UNFPA section for additional details). It is important to note that U.S. appropriations for a given year may be disbursed over a multi-year period. Appropriations have remained relatively flat for several years while disbursements have fluctuated largely due to the timing of payments.

    ← Return to text

  5. Includes core-contributions from members of the OECD DAC only; core contributions from n

    ← Return to text

  6. UNFPA, “UNFPA in 2019: Annual Report”, 2019. See also UNFPA Donor Contributions portal.

    ← Return to text

  7. In FY17, FY18, and FY19, the U.S. administration invoked the Kemp-Kasten amendment to withhold funding – both core and non-core contributions – to UNFPA. In each of these years, Congress required that funding withheld from UNFPA “shall be made available for family planning, maternal, and reproductive health activities.” See KFF “UNFPA Funding & Kemp-Kasten: An Explainer” for additional details.

    ← Return to text

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.